De Novo Superinfection of Hepatitis B Virus in an Anti-HBs Positive Patient with Recurrent Hepatitis C Following Liver Transplantation
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
A 60-year-old woman with end stage liver cirrhosis caused by genotype 2 hepatitis C virus (HCV) infection received an orthotopic liver transplantation (OLT). The patient was negative for the hepatitis B surface antigen (HBsAg) and positive for the anti-hepatitis B surface antibody (anti-HBs) prior to and one and a half months following the OLT. Due to reactivation of hepatitis C, treatment with interferon-alpha and Ribavirin started two months following the OLT and resulted in a sustained virological response. We performed a liver biopsy because a biochemical response was not achieved. Surprisingly,liver pathology showed HBsAg-positive hepatocytes with a lobular hepatitis feature, which had been negative in the liver biopsy specimen obtained one and a half months post-OLT. High titers of both HBsAg and HBeAg were detected,while anti-HBs antibodies were not found. Tests for IgM antihepatitis B core antibody and anti-delta virus antibodies were negative. The serum HBV DNA titer was over 1×10^7 copies/mL. A sequencing analysis showed no mutation in the “a”determinant region, but revealed a mixture of wild and mutant strains at an overlapping region of the S and P genes (S codon 213 (Leu/Ile); P codons 221 (Phe/Tyr) and 222 (Ala/Thr)). These findings suggest that de novo hepatitis B can develop in patients with HCV infection during the post-OLT period despite the presence of protective anti-HBs.
Abstract
A 60-year-old woman with end stage liver cirrhosis caused by genotype 2 hepatitis C virus (HCV) infection received an orthotopic liver transplantation (OLT). The patient was negative for the hepatitis B surface antigen (HBsAg) and positive for the anti-hepatitis B surface antibody (anti-HBs) prior to and one and a half months following the OLT. Due to reactivation of hepatitis C, treatment with interferon-alpha and Ribavirin started two months following the OLT and resulted in a sustained virological response. We performed a liver biopsy because a biochemical response was not achieved. Surprisingly,liver pathology showed HBsAg-positive hepatocytes with a lobular hepatitis feature, which had been negative in the liver biopsy specimen obtained one and a half months post-OLT. High titers of both HBsAg and HBeAg were detected,while anti-HBs antibodies were not found. Tests for IgM antihepatitis B core antibody and anti-delta virus antibodies were negative. The serum HBV DNA titer was over 1×10^7 copies/mL. A sequencing analysis showed no mutation in the “a”determinant region, but revealed a mixture of wild and mutant strains at an overlapping region of the S and P genes (S codon 213 (Leu/Ile); P codons 221 (Phe/Tyr) and 222 (Ala/Thr)). These findings suggest that de novo hepatitis B can develop in patients with HCV infection during the post-OLT period despite the presence of protective anti-HBs.
참고문헌 (15)
- Willems M, "Liver transplantation and hepatitis C", Transpl Int, 15, pp.61~72 (2002)
- Roche B, "De novo and apparent de novo hepatitis B virus infection after liver transplantation", J Hepatol, 26, pp.517~526 (1997)
- Dodson SF, "Infectivity of hepatic allografts with antibodies to hepatitis B virus", Transplantation, 64, pp.1582~1584 (1997)
- Uemoto S, "Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants", Transplantation, 65, pp.494~499 (1998)
- Barcena R, "Prevention of de novo HBV infection by the presence of anti-HBs in transplanted patients receiving core antibody-positive livers", World J Gastroenterol, 12, pp.2070~2074 (2006)
- Yoshida EM, "De novo acute hepatitis B infection in a previously vaccinated liver transplant recipient due to a strain of HBV with a Met 133 Thr mutation in the “a” determinant", Liver, 20, pp.411~414 (2000)
- Kim YJ, "Population genotyping of hepatitis C virus by matrix-assisted laser desorption", ionization timeof- flight mass spectrometry analysis of short DNA fragments, 2005, pp.51, 1123~1131
- Allain JP, "Occult hepatitis B virus infection", Transfus Clin Biol, 11, pp.18~25 (2004)
- Joya-Vazquez PP, "Impact of antihepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis", Transplantation, 73, pp.1598~1602 (2002)
- Kawatani T, "Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignancies", Eur J Haematol, 67, pp.45~50 (2001)
- Uchida T, "Hepatitis C virus is frequently coinfected with serum marker-negative hepatitis B virus: probable replication promotion of the former by the latter as demonstrated by in vitro cotransfection", J Med Virol, 52, pp.399~405 (1997)
- Torresi J, "The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus", J Clin Virol, 25, pp.97~106 (2002)
- Sagnelli E, "HBV superinfection in hepatitis C virus chronic carriers, viral interaction, and clinical course", Hepatology, 36, pp.1285~1291 (2002)
- Coffin CS, "Profound suppression of chronic hepatitis C following superinfection with hepatitis B virus", Liver Int, 27, pp.722~726 (2007)
- Willems M, "Liver transplantation and hepatitis C", Transpl Int, 15, pp.61~72 (2002)